Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 112.50%14.38M | -63.35%1.41M | 85.05%7.44M | -69.19%10.72M | -152.59%-3.82M | -34.09%6.77M | -61.30%3.86M | -45.03%4.02M | 128.97%34.8M | -13.81%7.26M |
| Net income from continuing operations | -887.20%-12.18M | 19.03%1.23M | 42.95%-4.15M | 476.11%25.4M | 1,884.18%30.1M | 482.92%1.55M | 340.65%1.03M | 2.15%-7.28M | -14.30%-6.75M | 232.37%1.52M |
| Operating gains losses | 624.86%908K | -288.65%-1.41M | -104.21%-83K | 396.35%975K | 125.57%668K | 77.06%-173K | 66.82%749K | -23.88%1.97M | -150.62%-329K | -749.75%-2.61M |
| Depreciation and amortization | 27.07%4.68M | -23.78%3.24M | 82.94%4.58M | 117.41%20.47M | 158.32%10.03M | 242.60%3.68M | 83.71%4.25M | 16.85%2.5M | 11.05%9.41M | 58.90%3.88M |
| Securities amortization | ---- | ---- | ---- | -210.85%-143K | -137.98%-49K | ---32K | ---31K | ---31K | --129K | --129K |
| Unrealized gains and losses of investment securities | --0 | -425.00%-13K | --0 | -194.12%-50K | -335.29%-74K | --17K | --4K | --3K | ---17K | ---17K |
| Remuneration paid in stock | -144.65%-271K | -17.56%521K | -98.47%10K | -41.09%1.64M | -136.08%-254K | -42.25%607K | 3.44%632K | 57.21%654K | -1.45%2.78M | 53.38%704K |
| Deferred tax | --0 | ---1.39M | ---- | -100.65%-50K | ---50K | --0 | --0 | ---- | 155.93%7.7M | ---- |
| Other non cashItems | -5.10%7.24M | 60.61%3.4M | 59.90%5.07M | -1,613.89%-15.91M | -363.75%-30.96M | 466.72%7.63M | 41.09%2.12M | -35.03%3.17M | -81.39%1.05M | -735.81%-6.68M |
| Change In working capital | 314.10%14M | 15.55%-4.16M | -32.81%2.01M | -203.79%-21.75M | -581.47%-13.27M | -182.24%-6.54M | -189.29%-4.93M | -36.57%3M | 4,073.51%20.95M | 34.29%2.76M |
| -Change in receivables | -259.98%-23.67M | -171.23%-6.14M | 47.48%-11.83M | -170.66%-18.21M | -51.73%2.28M | -228.75%-6.58M | 94.36%8.62M | -62.36%-22.53M | 69.92%-6.73M | 154.33%4.71M |
| -Change in inventory | 237.23%1.54M | -166.62%-2.59M | 145.08%2.28M | -240.99%-3.02M | -143.19%-736K | -160.90%-1.12M | 189.25%3.89M | -270.81%-5.06M | 468.17%2.14M | 405.92%1.7M |
| -Change in payables and accrued expense | 3,188.44%36.14M | 127.09%4.7M | -62.31%11.52M | -117.37%-4.46M | -431.75%-18.76M | -86.63%1.1M | -432.47%-17.36M | 94.06%30.56M | 14.10%25.66M | -131.27%-3.53M |
| -Change in other working capital | -107.27%-4K | -55.42%-129K | 128.57%48K | 3,303.25%3.94M | 3,090.15%3.95M | 152.38%55K | -137.22%-83K | 119.27%21K | ---123K | ---132K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 112.50%14.38M | -63.35%1.41M | 85.05%7.44M | -69.19%10.72M | -152.59%-3.82M | -34.09%6.77M | -61.30%3.86M | -45.03%4.02M | 128.97%34.8M | -13.81%7.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -32.45%-3.83M | -211.88%-8.83M | -21.69%-8.55M | 62.29%-22.42M | -89.54%-20.39M | 84.34%-2.89M | 143.85%7.9M | 42.51%-7.03M | -64.62%-59.44M | 31.50%-10.76M |
| Net PPE purchase and sale | -256.55%-5.85M | -115.20%-1.79M | 8.65%-5.95M | 81.34%-10.29M | -17.72%-13.91M | 90.35%-1.64M | 171.81%11.77M | 34.44%-6.51M | -110.63%-55.15M | 16.22%-11.82M |
| Net business purchase and sale | --0 | ---628K | ---- | --0 | --0 | --0 | --0 | --0 | --3.89M | --6.26M |
| Net investment purchase and sale | --2.01M | -6,683.33%-1.19M | -4,676.00%-1.14M | -32.80%-5.19M | -2.23%-5.23M | --0 | -81.25%18K | -98.31%25K | -170.15%-3.91M | -252.86%-5.12M |
| Net other investing changes | 100.72%9K | -34.30%-5.23M | -169.69%-1.46M | -62.40%-6.94M | -1,353.49%-1.25M | -15.85%-1.25M | -150.32%-3.9M | 69.91%-541K | 49.62%-4.27M | 43.79%-86K |
| Cash from discontinued investing activities | 45M | 0 | ||||||||
| Investing cash flow | -32.45%-3.83M | -211.88%-8.83M | -21.69%-8.55M | 137.99%22.58M | 328.68%24.61M | 84.34%-2.89M | 143.85%7.9M | 42.51%-7.03M | -64.62%-59.44M | 31.50%-10.76M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10.14%891K | 15.38%-7.27M | -273.07%-4.8M | -139.54%-7.67M | 63.63%-2.77M | -94.24%809K | -87.16%-8.59M | -84.18%2.77M | -23.33%19.39M | -297.74%-7.61M |
| Net issuance payments of debt | -44.64%1.63M | 0.68%-7.28M | -173.05%-2.81M | -119.42%-3.14M | 84.83%-2.61M | -80.23%2.95M | -511.59%-7.33M | -60.20%3.85M | -46.52%16.18M | -376.05%-17.22M |
| Net common stock issuance | ---- | ---- | ---- | ---94K | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --145K | ---- | ---- | --0 | --0 | --0 | --0 | ---- | -92.95%17K | -91.51%9K |
| Interest paid (cash flow from financing activities) | 46.65%-980K | 11.91%-954K | -40.43%-1.11M | 30.71%-3.25M | 122.08%460K | -445.10%-1.84M | -26.22%-1.08M | 44.08%-789K | -14.84%-4.69M | 13.75%-2.08M |
| Net other financing activities | 130.59%93K | 667.84%971K | -204.15%-879K | -115.00%-1.18M | -104.48%-523K | 42.21%-304K | 93.27%-171K | -103.12%-289K | 798.67%7.88M | 6,551.93%11.68M |
| Cash from discontinued financing activities | 0 | 0 | -7M | 7M | ||||||
| Financing cash flow | 10.14%891K | 53.38%-7.27M | -149.12%-4.8M | -139.54%-7.67M | 63.63%-2.77M | -94.24%809K | -239.73%-15.59M | -44.26%9.77M | -23.33%19.39M | -303.18%-7.61M |
| Net cash flow | ||||||||||
| Beginning cash position | 69.79%5.71M | 182.19%20.22M | 6,218.45%26.03M | -93.04%412K | -31.27%7.95M | -42.02%3.36M | -61.40%7.17M | -93.04%412K | 243.05%5.92M | 22.14%11.57M |
| Current changes in cash | 144.20%11.44M | -282.77%-14.69M | -187.38%-5.91M | 587.93%25.64M | 262.09%18.02M | -20.13%4.69M | 69.62%-3.84M | -46.40%6.77M | -219.98%-5.25M | -213.95%-11.12M |
| Effect of exchange rate changes | -525.77%-607K | 440.63%173K | 157.14%8K | 93.73%-16K | 275.00%63K | 0.00%-97K | 123.36%32K | -193.33%-14K | -38.59%-255K | -414.29%-36K |
| End cash Position | 108.09%16.54M | 69.79%5.71M | 180.91%20.13M | 6,218.45%26.03M | 6,218.45%26.03M | -31.27%7.95M | -42.02%3.36M | -61.40%7.17M | -93.04%412K | -93.04%412K |
| Free cash from | -104.27%-219K | -166.99%-420K | 159.86%1.49M | 102.12%432K | 40.22%-2.73M | 176.01%5.13M | 109.75%627K | 4.85%-2.49M | -85.26%-20.35M | 19.77%-4.56M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.